24-Hour Update: House Committee Requests GAO Investigation Into White House Vaccine Order; June ACIP Meeting Remains Removed; No New USPSTF Appointments; Blocked Studies Unpublished
Published: June 5, 2026
By: Zeeshan Khan
Reading time: 17 minutes
Category: Public Health / Government Policy / Vaccines / Legal
Note: June 5, 2026 – This is an update to the June 4, 2026 article: The Vaccine Data Blackout: Executive Order Defies Court Ruling as June ACIP Meeting Removed
WASHINGTON, D.C. – June 5, 2026 – In the 24 hours since the previous update, the House Committee on Energy and Commerce has formally requested that the Government Accountability Office (GAO) investigate the White House executive order on vaccine schedules, marking the first official congressional probe into the June 2 order. The June 24-26, 2026 ACIP meeting remains removed from the CDC website, with no official explanation provided. ACIP remains without appointed members, the March court stay remains in effect, the USPSTF remains paralyzed with no appointments announced nearly two weeks after the nomination period closed, and the three blocked vaccine safety studies remain unpublished.
The Essentials: Who, What, When, Where, Why, How (Last 24 Hours)
Who: The House Committee on Energy and Commerce; the Government Accountability Office (GAO); the White House; the Centers for Disease Control and Prevention (CDC); the Advisory Committee on Immunization Practices (ACIP); the Department of Health and Human Services (HHS); HHS Secretary Robert F. Kennedy Jr.; the Food and Drug Administration (FDA); the U.S. Preventive Services Task Force (USPSTF); the federal court system; the Senate Permanent Subcommittee on Investigations (Chairman Ron Johnson, R-WI); and the American Academy of Pediatrics (AAP).
What: The House Committee on Energy and Commerce sent a formal letter to the GAO on June 5, 2026, requesting an investigation into the White House executive order issued June 2, 2026. The June 24-26, 2026 ACIP meeting remains removed from the CDC website. ACIP has no members. The March court stay remains in effect. The USPSTF has no new appointments. The three blocked vaccine studies remain unpublished.
When: The House GAO investigation request was made on June 5, 2026. The executive order was issued on June 2, 2026. The June ACIP meeting was removed from the CDC website as of June 3, 2026. The data in this report is current as of June 5, 2026, 10:00 EST.
Where: These developments apply to federal vaccine advisory committees operating out of the CDC in Atlanta, Georgia, and HHS in Washington, D.C., affecting national vaccine policy for all 50 states. The GAO investigation will be conducted from GAO headquarters in Washington, D.C.
Why (Immediate Cause): The House committee requested the GAO investigation to examine whether the executive order followed proper administrative procedures and to assess its potential impact on public health. Legal experts have stated the order conflicts with the March 2026 court ruling that blocked ACIP from making recommendations.
How (Mechanism): The GAO investigation operates under congressional oversight authority. The House Committee on Energy and Commerce exercises jurisdiction over public health and FDA/CDC matters. The executive order directs CDC and ACIP under existing executive authority. The March court ruling remains in effect through the federal judiciary.
Specific Updates in the Last 24 Hours (June 4–5, 2026)
1. House Committee Requests GAO Investigation Into Executive Order
On June 5, 2026, the House Committee on Energy and Commerce sent a formal letter to the Government Accountability Office (GAO) requesting an investigation into the White House executive order issued June 2, 2026.
What the GAO Investigation Will Examine: The request specifically asks the GAO to examine whether the order followed proper administrative procedures and to assess its potential impact on public health.
Significance of the Request: This represents the first formal congressional oversight action specifically targeting the executive order. As reported in the June 4 article, legal experts had already stated the order “flies in the face” of the March federal court ruling. The GAO investigation adds a new layer of congressional scrutiny to the legal conflict.
Current Status: The GAO has received the request but has not yet announced whether it will accept the investigation or when it might be completed. The executive order has been issued but not yet implemented.
2. Legal Conflict Remains Unresolved – Executive Order Still Active
As reported in the June 4 article, the executive order conflicts with the March 2026 federal court ruling.
Active Court Ruling Context: A federal judge ruled in March 2026 that HHS Secretary Kennedy’s previous overhaul of ACIP and changes to the vaccine schedule were likely unlawful. The ruling temporarily blocked ACIP from meeting or making recommendations.
Attorney Statement (Previously Reported): Richard Hughes IV, the attorney representing the American Academy of Pediatrics (AAP) in the ongoing lawsuit, said the order “flies in the face of the judge’s order in our case” and is “promoting a deceptive vaccine policy narrative.”
Legal Warning (Previously Reported): Hughes stated that “any further actions that match the previous unlawful patterns of appointments and recommendations are going to be met with legal action.”
Current Status: The executive order remains in effect on paper but has not been implemented. The March court stay remains in effect. ACIP has no appointed members and cannot issue recommendations.
3. June 24-26, 2026 ACIP Meeting Remains Removed from CDC Website (No Change)
As previously reported on June 3, 2026, the June 24-26, 2026 ACIP meeting has been removed from the CDC website. As of June 5, 2026, that removal remains in effect.
Current CDC Website Status: The CDC’s ACIP meeting information page no longer shows the June 24-26, 2026 meeting. The next meeting now listed is October 21-23, 2026.
No Official Explanation: As of June 5, 2026, the CDC and HHS have not issued any public announcement explaining why the June meeting was removed or whether it has been cancelled, postponed, or simply unlisted.
Significance: The removal of the June meeting suggests that ACIP will not proceed with scheduled meetings while the court stay and membership vacancies remain unresolved.
4. ACIP Status: Valid Charter, No Members, Court Stay in Effect (Unchanged)
The underlying status of ACIP remains unchanged as of June 5, 2026:
| Metric | Status as of June 5, 2026 |
|---|---|
| Charter status | VALID – Re-established May 19, 2026, for two years |
| Committee members | NONE – Membership to be determined |
| March court ruling | IN EFFECT – Blocks previous Kennedy appointees |
| Administration appeal | PENDING – Appeal of March ruling continues |
| Next meeting listed | OCTOBER 21-23, 2026 on CDC website |
Implication: Even if the October meeting proceeds as listed, ACIP cannot issue recommendations while the court stay remains in effect. The committee also cannot function without appointed members. The executive order cannot override the court ruling.
5. USPSTF Remains Paralyzed – No Appointments Announced (Unchanged)
The USPSTF nomination period closed on May 23, 2026. As of June 5, 2026, no new appointments have been announced.
| Metric | Status as of June 5, 2026 |
|---|---|
| Nomination period | CLOSED (as of May 23, 2026) |
| Total positions | 16 |
| Current vacancies | 8 (half of all positions) |
| Last meeting | Over one year ago |
| Fired vice-chairs | 2 (Dr. John Wong and Dr. Esa Davis) |
| Reapplication status | Both reapplied for non-leadership positions |
| New appointments announced | NONE |
| Next meeting scheduled | NONE |
6. Blocked Vaccine Studies Remain Unpublished (Unchanged)
The three vaccine safety studies identified in previous reporting remain unpublished as of June 5, 2026.
Studies at Issue:
- COVID-19 vaccine safety study covering 4.2 million patients
- Shingles vaccine (Shingrix) safety abstracts
- CDC MMWR COVID-19 effectiveness report
Senate Hearing Context (Previously Reported): The Senate Permanent Subcommittee on Investigations held a hearing on June 3, 2026, examining the FDA’s decision to block publication of these studies. As of June 5, 2026, no announcements regarding their release have been made.
7. FDA Pediatric Death Review Findings Unchanged (Confirmed)
The FDA pediatric death review findings reported in previous articles remain confirmed and unchanged as of June 5, 2026.
Confirmed Classification of the 96 Pediatric Deaths:
| Classification | Number of Deaths |
|---|---|
| Definitely related to vaccination | 0 |
| Likely related to vaccination | 2 |
| Possibly related to vaccination | 5 |
| Unlikely related to vaccination | 62 |
| Unable to be assessed | 27 |
Demographics of the Seven Cases Classified as “Likely” or “Possible”:
- Age range: 7 to 16 years (median age 13)
- Time to symptom onset: Median of 3 days post-vaccination
- Vaccine type: All cases followed Pfizer-BioNTech vaccination
- Clinical presentation: All seven cases involved cardiac events
Important Distinction: The WHO-UMC causality framework explicitly states that “likely” and “possible” classifications cannot definitely prove a link between a drug or vaccine and a particular adverse event. The FDA report explicitly states that it “does not constitute a benefit-risk analysis” and does not recommend changing who should receive vaccination.
8. CMS Data Reporting Change Remains in Effect (Unchanged)
The Centers for Medicare & Medicaid Services (CMS) data reporting change remains in effect as of June 5, 2026. States are still not required to report childhood immunization status for the nearly 40% of American children covered by Medicaid and CHIP.
Comparison: Before (June 4 Article) and After (June 5 – Current)
| Issue | As of June 4, 2026 (Article) | As of June 5, 2026 (Current) |
|---|---|---|
| House GAO investigation into executive order | NOT MENTIONED | REQUESTED – June 5, 2026 |
| Legal conflict with March court ruling | CONFIRMED – Attorney Hughes states order “flies in the face” of ruling | UNCHANGED – Conflict remains unresolved |
| June 24-26, 2026 ACIP meeting | REMOVED as of June 3 | REMAINS REMOVED – No change |
| Next ACIP meeting listed | October 21-23, 2026 | UNCHANGED – October 21-23, 2026 |
| Official explanation for removal | NONE | NONE – No announcement issued |
| ACIP charter status | VALID – Unchanged | VALID – Unchanged |
| ACIP members | NONE | NONE – No appointments |
| March court ruling | IN EFFECT | IN EFFECT – Unchanged |
| USPSTF appointments | NONE | NONE – No appointments |
| Blocked vaccine studies | BLOCKED – Unpublished; Senate hearing held | BLOCKED – Unpublished; no change |
Timeline of Key Events (Updated Through June 5, 2026)
| Date | Event |
|---|---|
| June 2025 | Kennedy ousts all 17 ACIP members |
| December 2025 | FACA amended – new public notification requirements |
| March 2026 | Federal judge blocks Kennedy’s ACIP appointments; ruling questioned qualifications |
| April 6, 2026 | Initial charter renewal notice filed |
| May 11, 2026 | FDA blocks vaccine safety studies |
| May 14, 2026 | Kennedy signs new charter (scales back expertise requirements) |
| May 18, 2026 | New charter notice filed in Federal Register (re-establishes ACIP) |
| May 19, 2026 | New charter becomes effective |
| May 19, 2026 | Kennedy fires USPSTF vice-chairs (Drs. Wong and Davis) |
| May 21, 2026 | HHS withdraws May 14 charter citing “administrative error” |
| May 23, 2026 | USPSTF nomination period closes |
| May 26, 2026 | Federal Register notice publicly accessible |
| May 27, 2026 | Professor Reiss confirms withdrawal was a procedural violation |
| May 28, 2026 | CIDRAP publishes analysis of FDA pediatric death review |
| May 29, 2026 | Article published noting June ACIP meeting still listed |
| June 2, 2026 | White House issues executive order on vaccine schedules |
| June 3, 2026 | June ACIP meeting removed from CDC website |
| June 3, 2026 | Senate subcommittee holds hearing on blocked vaccine studies |
| June 4, 2026 | Article published: Executive order, Senate hearing, continued removal |
| June 5, 2026 | House Committee requests GAO investigation into executive order |
Why This Matters to the Average Person (Updated for June 5)
These developments affect every American who relies on vaccines, preventive health screenings, or the integrity of federal scientific advisory committees.
The House Has Launched a GAO Probe Into the Executive Order: On June 5, 2026, the House Committee on Energy and Commerce formally requested that the GAO investigate the White House executive order on vaccine schedules. This represents the first official congressional oversight action targeting the order, which legal experts have said “flies in the face” of an active federal court ruling.
The June ACIP Meeting Remains Removed: The committee that determines which vaccines are recommended for children and adults had a June meeting listed on the CDC website as recently as May 29. As of June 5, that meeting remains removed. The next listed meeting is October 21-23, 2026. No official explanation has been provided.
ACIP Has a Charter – But Cannot Function: ACIP has a valid charter re-established on May 19, 2026, for a two-year period. However, the committee cannot meet or issue guidance until members are appointed in compliance with the March court ruling. As of June 5, no members have been appointed. The court stay remains in effect.
USPSTF Remains Paralyzed – No End in Sight: The task force that determines which preventive services must be covered with no out-of-pocket costs under the Affordable Care Act remains unable to function. With no meetings in over a year, half the positions vacant, and no appointments announced nearly two weeks after the nomination period closed, no new recommendations are being developed.
Blocked Studies Remain Suppressed: The Senate held a hearing on June 3, but the FDA and CDC have not released the blocked vaccine safety and effectiveness studies. The 4.2 million-patient COVID-19 safety study, the Shingrix safety abstracts, and the CDC MMWR effectiveness report remain unpublished.
Arguments In Favor of the Administration’s Actions (Updated)
Supporters of the administration’s approach argue that the executive order promotes transparency and that the GAO investigation is a routine oversight matter.
- Executive Order Promotes Alignment with Global Standards: The order directs ACIP to consider vaccine schedules used by peer nations, which may provide useful comparative data.
- Safety Surveillance Is Working: The FDA OBPV conducted a thorough review of pediatric deaths and found zero classified as “definite.” The review recommended a class safety labeling change, which truthfully reflects the situation.
- ACIP Has Been Re-Established: Contrary to concerns that the committee would remain defunct, the administration has re-established ACIP with a two-year charter.
- GAO Investigation Is Standard Procedure: Congressional requests for GAO investigations are a routine part of oversight and do not imply wrongdoing.
Arguments Against the Administration’s Actions (Updated)
Critics argue that the executive order directly conflicts with a federal court ruling and that the administration continues to suppress scientific work.
- The Executive Order Defies a Court Ruling: The March 2026 federal court ruling explicitly blocked ACIP from making recommendations. The attorney for the AAP states the order “flies in the face of the judge’s order.”
- Legal Consequences Are Likely: Hughes warned that “any further actions that match the previous unlawful patterns of appointments and recommendations are going to be met with legal action.”
- The June Meeting Removal Remains Unexplained: As of June 5, the CDC has provided no official explanation for why the June 24-26 meeting was removed from the website.
- ACIP Has No Members and a Court Stay Remains in Effect: While the charter is now valid, the committee has no members. The October meeting is listed, but ACIP cannot act while the court stay remains in effect.
- USPSTF Remains Paralyzed: The nomination period closed on May 23. As of June 5, no new appointments have been announced. The task force has not met in over a year.
- Blocked Studies Remain Suppressed: The Senate held a hearing on June 3, but the FDA and CDC have not released the blocked vaccine safety and effectiveness studies.
Current Status Summary (As of June 5, 2026, 10:00 EST)
| Question | Answer |
|---|---|
| Has the House requested a GAO investigation into the executive order? | YES – June 5, 2026 |
| Has the GAO accepted or declined the investigation request? | NOT YET ANNOUNCED |
| Does the order conflict with the March court ruling? | YES – Legal experts confirm direct conflict |
| Has legal action been threatened regarding the order? | YES – AAP attorney warns of legal action |
| Is the June 24-26, 2026 ACIP meeting listed on the CDC website? | NO – Removed as of June 3; remains removed |
| What is the next ACIP meeting listed on the CDC website? | OCTOBER 21-23, 2026 |
| Has the CDC or HHS issued an explanation for the removal? | NO – No official announcement as of June 5 |
| Did the Senate hold a hearing on blocked vaccine studies? | YES – June 3, 2026 |
| Has ACIP been formally re-established? | YES – Charter effective May 19, 2026 |
| Does ACIP have members? | NO – Membership to be determined; no appointments announced |
| Is the March court ruling still in effect? | YES – Remains in effect; administration has appealed |
| How many pediatric deaths were classified as “definite” in the FDA review? | 0 – Zero deaths classified as definitely caused by vaccination |
| How many were classified as “likely” or “possible”? | 7 total (2 likely, 5 possible) |
| Is the USPSTF nomination period open? | NO – Closed May 23, 2026 |
| How many USPSTF positions are vacant? | 8 of 16 |
| Have new USPSTF appointments been announced? | NO – None as of June 5, 2026 |
| Did FDA block vaccine studies? | YES – COVID and shingles vaccine safety studies remain unpublished |
| Has the CMS data reporting requirement been restored? | NO – Remains voluntary |
What Happens Next (Updated for June 5)
Immediate term (hours to days):
- GAO Response Expected – The GAO may announce whether it will accept or decline the House committee’s investigation request. If accepted, the GAO will establish a timeline for completion.
- Legal challenges to the executive order remain likely – with AAP attorney Hughes stating “any further actions… are going to be met with legal action”
- The CDC or HHS may issue an explanation for the removal of the June ACIP meeting from the website
- Secretary Kennedy may announce USPSTF appointments – no announcements made nearly two weeks after nomination period closed
Short term (weeks):
- The court’s stay on ACIP action remains in effect – ACIP cannot issue recommendations unless the stay is lifted
- The administration’s appeal of the March court ruling continues
- ACIP membership must be finalized in compliance with the March court ruling – but no timeline has been announced
- The Senate subcommittee may release findings from the June 3 hearing
Long term (months):
- The October 21-23, 2026 ACIP meeting is listed – its status will depend on whether members are appointed, the court stay is lifted, and the executive order is challenged
- The cumulative effect of CMS data removal, delayed ACIP meetings, USPSTF vacancies, and blocked studies could accelerate declines in vaccination rates and preventive care utilization
- Additional congressional oversight hearings may be requested
- If GAO accepts the investigation, a report could be published – GAO investigations typically take several months to complete
Sources
- House Committee on Energy and Commerce (June 5, 2026) – Formal letter to Government Accountability Office requesting investigation into White House executive order on vaccine schedules – Investigation request confirmation; scope of examination
- Medscape (June 3, 2026) – “Executive Order on Vaccine Schedule ‘Flies in the Face’ of Federal Ruling” – Executive order details; Attorney Richard Hughes IV statements; legal conflict confirmation
- Centers for Disease Control and Prevention (CDC) – ACIP meeting information page accessed June 5, 2026 – June 24-26, 2026 meeting removed; October 21-23, 2026 shown as next meeting
- Legis1 (June 1, 2026) – “FDA Suppressed Vaccine Safety Research: Senate Investigates” – Senate Permanent Subcommittee on Investigations hearing announcement; Chairman Ron Johnson (R-WI)
- MedPage Today (May 18, 2026) – “HHS Withdraws New Rules for CDC Vaccine Panel” – ACIP charter withdrawal and re-establishment
- Federal Register (May 18, 2026) – “Advisory Committee on Immunization Practices (ACIP): Charter Re-establishment Notice” – Official filing, effective date May 19, 2026
- Techdirt (May 22, 2026) – “FDA Blocks Publication of Vaccine Safety Studies” – Dr. Aaron S. Kesselheim “censorship” comments
- CIDRAP (May 28, 2026) – “Manufacturing a scandal: What the FDA’s COVID vaccine pediatric death review actually says” – Detailed analysis of 73-page OBPV report, 0 definite deaths, 2 likely, 5 possible
- Previous article: The Vaccine Data Blackout: Executive Order Defies Court Ruling as June ACIP Meeting Removed (The 5 Ws, June 4, 2026) – Baseline status as of June 4
The 5 W's 
Leave a comment